Drug-eluting Microspheres Compared to Conventional Transarterial Chemoembolization as First Line Treatment for Unresectable Hepatocellular Carcinoma: A Single-center Retrospective Cost-utility Analysis

PURPOSE: To assess the cost-utility of initial treatment with drug-eluting microspheres (DEM) transarterial chemoembolization (TACE) versus conventional (C)-TACE in patients with hepatocellular carcinoma considering the perspective of a Local Healthcare Authority in Italy. MATERIALS AND METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreozzi, G., Lorenzoni, V., Bargellini, I., Cioni, R., Turchetti, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Scientific Paper (Other)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014672/
https://www.ncbi.nlm.nih.gov/pubmed/36599950
http://dx.doi.org/10.1007/s00270-022-03335-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014672/
https://www.ncbi.nlm.nih.gov/pubmed/36599950
http://dx.doi.org/10.1007/s00270-022-03335-4

Ejemplares similares